A citation-based method for searching scientific literature


List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
100


Crowdsourcing drug discovery for pandemics.
John Chodera, Alpha A Lee, Nir London, Frank von Delft. Nat Chem 2020
53
50

SwissParam: a fast force field generation tool for small organic molecules.
Vincent Zoete, Michel A Cuendet, Aurélien Grosdidier, Olivier Michielin. J Comput Chem 2011
811
50

Remdesivir for the Treatment of Covid-19 - Final Report.
John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Elizabeth Hohmann, Helen Y Chu, Annie Luetkemeyer, Susan Kline,[...]. N Engl J Med 2020
50

Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.
Zhenming Jin, Yao Zhao, Yuan Sun, Bing Zhang, Haofeng Wang, Yan Wu, Yan Zhu, Chen Zhu, Tianyu Hu, Xiaoyu Du,[...]. Nat Struct Mol Biol 2020
210
50

Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.
Jesús Villar, Carlos Ferrando, Domingo Martínez, Alfonso Ambrós, Tomás Muñoz, Juan A Soler, Gerardo Aguilar, Francisco Alba, Elena González-Higueras, Luís A Conesa,[...]. Lancet Respir Med 2020
455
50

Predicting retrosynthetic pathways using transformer-based models and a hyper-graph exploration strategy.
Philippe Schwaller, Riccardo Petraglia, Valerio Zullo, Vishnu H Nair, Rico Andreas Haeuselmann, Riccardo Pisoni, Costas Bekas, Anna Iuliano, Teodoro Laino. Chem Sci 2020
43
50

MM/GBSA binding energy prediction on the PDBbind data set: successes, failures, and directions for further improvement.
Paulette A Greenidge, Christian Kramer, Jean-Christophe Mozziconacci, Romain M Wolf. J Chem Inf Model 2013
151
50

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Wenhao Dai, Bing Zhang, Xia-Ming Jiang, Haixia Su, Jian Li, Yao Zhao, Xiong Xie, Zhenming Jin, Jingjing Peng, Fengjiang Liu,[...]. Science 2020
659
50

Computationally efficient methodology for atomic-level characterization of dendrimer-drug complexes: a comparison of amine- and acetyl-terminated PAMAM.
Ariela Vergara-Jaque, Jeffrey Comer, Luis Monsalve, Fernando D González-Nilo, Claudia Sandoval. J Phys Chem B 2013
53
50

SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity.
Tomonari Muramatsu, Chie Takemoto, Yong-Tae Kim, Hongfei Wang, Wataru Nishii, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama. Proc Natl Acad Sci U S A 2016
132
50

The SARS-CoV-2 main protease as drug target.
Sven Ullrich, Christoph Nitsche. Bioorg Med Chem Lett 2020
239
50

Automated extraction of chemical synthesis actions from experimental procedures.
Alain C Vaucher, Federico Zipoli, Joppe Geluykens, Vishnu H Nair, Philippe Schwaller, Teodoro Laino. Nat Commun 2020
21
50

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.
Thijs Kuiken, Ron A M Fouchier, Martin Schutten, Guus F Rimmelzwaan, Geert van Amerongen, Debby van Riel, Jon D Laman, Ton de Jong, Gerard van Doornum, Wilina Lim,[...]. Lancet 2003
727
50


Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.
Alice Douangamath, Daren Fearon, Paul Gehrtz, Tobias Krojer, Petra Lukacik, C David Owen, Efrat Resnick, Claire Strain-Damerell, Anthony Aimon, Péter Ábrányi-Balogh,[...]. Nat Commun 2020
173
50


Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power.
Zhe Wang, Huiyong Sun, Xiaojun Yao, Dan Li, Lei Xu, Youyong Li, Sheng Tian, Tingjun Hou. Phys Chem Chem Phys 2016
351
50

The rise of fragment-based drug discovery.
Christopher W Murray, David C Rees. Nat Chem 2009
426
50


Molecular dynamics simulations of biomolecules.
Martin Karplus, J Andrew McCammon. Nat Struct Biol 2002
50


Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design.
Xiaoyu Xue, Hongwei Yu, Haitao Yang, Fei Xue, Zhixin Wu, Wei Shen, Jun Li, Zhe Zhou, Yi Ding, Qi Zhao,[...]. J Virol 2008
254
50


The 'rule of three' for fragment-based drug discovery: where are we now?
Harren Jhoti, Glyn Williams, David C Rees, Christopher W Murray. Nat Rev Drug Discov 2013
133
50

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
50

A new coronavirus associated with human respiratory disease in China.
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, Yi Hu, Zhao-Wu Tao, Jun-Hua Tian, Yuan-Yuan Pei,[...]. Nature 2020
50

Challenges in protein folding simulations: Timescale, representation, and analysis.
Peter L Freddolino, Christopher B Harrison, Yanxin Liu, Klaus Schulten. Nat Phys 2010
198
50

All-atom empirical potential for molecular modeling and dynamics studies of proteins.
A D MacKerell, D Bashford, M Bellott, R L Dunbrack, J D Evanseck, M J Field, S Fischer, J Gao, H Guo, S Ha,[...]. J Phys Chem B 1998
50

Scalable molecular dynamics with NAMD.
James C Phillips, Rosemary Braun, Wei Wang, James Gumbart, Emad Tajkhorshid, Elizabeth Villa, Christophe Chipot, Robert D Skeel, Laxmikant Kalé, Klaus Schulten. J Comput Chem 2005
50

Structural insights into SARS-CoV-2 proteins.
Rimanshee Arya, Shweta Kumari, Bharati Pandey, Hiral Mistry, Subhash C Bihani, Amit Das, Vishal Prashar, Gagan D Gupta, Lata Panicker, Mukesh Kumar. J Mol Biol 2021
75
50

Bioactive natural compounds against human coronaviruses: a review and perspective.
Yanfang Xian, Juan Zhang, Zhaoxiang Bian, Hua Zhou, Zhenbiao Zhang, Zhixiu Lin, Hongxi Xu. Acta Pharm Sin B 2020
70
50

Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).
Dae-Gyun Ahn, Hye-Jin Shin, Mi-Hwa Kim, Sunhee Lee, Hae-Soo Kim, Jinjong Myoung, Bum-Tae Kim, Seong-Jun Kim. J Microbiol Biotechnol 2020
436
50

Advancing Drug Discovery via Artificial Intelligence.
H C Stephen Chan, Hanbin Shan, Thamani Dahoun, Horst Vogel, Shuguang Yuan. Trends Pharmacol Sci 2019
9
50

Review of registered clinical trials for the treatment of COVID-19.
Fatemeh Babaei, Mohammadreza Mirzababaei, Marjan Nassiri-Asl, Hossein Hosseinzadeh. Drug Dev Res 2021
11
50

Genetic Variants of SARS-CoV-2-What Do They Mean?
Adam S Lauring, Emma B Hodcroft. JAMA 2021
283
50

Definition and testing of the GROMOS force-field versions 54A7 and 54B7.
Nathan Schmid, Andreas P Eichenberger, Alexandra Choutko, Sereina Riniker, Moritz Winger, Alan E Mark, Wilfred F van Gunsteren. Eur Biophys J 2011
50

BDDCS, the Rule of 5 and drugability.
Leslie Z Benet, Chelsea M Hosey, Oleg Ursu, Tudor I Oprea. Adv Drug Deliv Rev 2016
142
50

Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
L Tao, P Zhang, C Qin, S Y Chen, C Zhang, Z Chen, F Zhu, S Y Yang, Y Q Wei, Y Z Chen. Adv Drug Deliv Rev 2015
38
50

Ligand-based approach for predicting drug targets and for virtual screening against COVID-19.
Yanqing Yang, Zhengdan Zhu, Xiaoyu Wang, Xinben Zhang, Kaijie Mu, Yulong Shi, Cheng Peng, Zhijian Xu, Weiliang Zhu. Brief Bioinform 2021
13
50

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19).
Surjeet Verma, Danielle Twilley, Tenille Esmear, Carel B Oosthuizen, Anna-Mari Reid, Marizé Nel, Namrita Lall. Front Pharmacol 2020
50
50

Anticancer compounds from cyanobacterium Lyngbya species: a review.
Shasank S Swain, Rabindra N Padhy, Pawan K Singh. Antonie Van Leeuwenhoek 2015
12
50

Nano strategies for berberine delivery, a natural alkaloid of Berberis.
Elaheh Mirhadi, Mehdi Rezaee, Bizhan Malaekeh-Nikouei. Biomed Pharmacother 2018
61
50

P-glycoprotein Inhibition for Optimal Drug Delivery.
Md Lutful Amin. Drug Target Insights 2013
280
50

The Biological Activity of Natural Alkaloids against Herbivores, Cancerous Cells and Pathogens.
Amin Thawabteh, Salma Juma, Mariam Bader, Donia Karaman, Laura Scrano, Sabino A Bufo, Rafik Karaman. Toxins (Basel) 2019
48
50

Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations.
Mohamed Hagar, Hoda A Ahmed, Ghadah Aljohani, Omaima A Alhaddad. Int J Mol Sci 2020
57
50

Accelerating the semisynthesis of alkaloid-based drugs through metabolic engineering.
Amy M Ehrenworth, Pamela Peralta-Yahya. Nat Chem Biol 2017
40
50

Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae.
Shasank S Swain, Sudhir K Paidesetty, Budheswar Dehury, Madhusmita Das, Sundeep C Vedithi, Rabindra N Padhy. Sci Rep 2020
14
50

Physiology of Intestinal Absorption and Secretion.
Pawel R Kiela, Fayez K Ghishan. Best Pract Res Clin Gastroenterol 2016
228
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.